CTSO — CYTOSORBENTS CORP

Ownership history in Pathstone Holdings, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which Pathstone Holdings, LLC reported a position in CYTOSORBENTS CORP (CTSO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 499,955 — — 0.00% $320K $0.64
% of Fund (quarterly)    CTSO price (monthly, adj. close)

Other funds also holding CTSO

As of 2025 Q4 — sorted by position size

CM Management, LLC 3Y 0.8% AVENIR CORP 3Y 7Y 0.36% Skylands Capital, LLC 3Y 7Y 0.16% Sargent Investment Group, LLC 3Y 7Y 0.05% Key Client Fiduciary Advisors, LLC 3Y 0.02% Seelaus Asset Management LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% NWF Advisory Services Inc. 0.01% Neuberger Berman Group LLC 3Y 7Y 0.0% Compound Planning, Inc. 0.0%
← Back to Pathstone Holdings, LLC Holdings